Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluzoparib + QL1101 maintenance in advanced ovarian cancer
NCT05585281Phase 2Recruiting
- Start
- Jul 2023
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluzoparib in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC). Started Jul 2023; status: recruiting.
02
Drugs
fluzoparib
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT05585281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05585281.